Careers  |  Sign In  |  Register

Dr. Polsky on the Clinical Validity of ctDNA in BRAF-Mutant Melanoma

In this interview, David Polsky, MD, PhD, shares details about his advanced laboratory tumor detection technology and the study results presented at ASCO 2020. Dr. Polsky suggests that testing for circulating tumor DNA is the most precise methodology available and that his highest ever reported detection rate is evidence to support this conclusion.

Learn more by clicking here.